Dr. Sharman is a practicing hematologist / oncologist and serves as the medical director of hematology research for the US Oncology network where he has helped build one of the largest clinical research groups studying blood cancer. Dr. Sharman pioneered the use of B-cell receptor antagonists and has played a role in development of several antibody-drug conjugates, immunotherapies, targeted agents, and cellular therapies.  He been engaged as a key opinion leader and served as a strategic consultant to many pharmaceutical companies designing and interpreting clinical trials to help position novel therapeutics for regulatory and commercial success.  He has served on numerous pharmaceutical scientific boards and steering committees.